1. Home
  2. WEYS vs BCYC Comparison

WEYS vs BCYC Comparison

Compare WEYS & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$34.54

Market Cap

331.9M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.44

Market Cap

310.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEYS
BCYC
Founded
1906
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.9M
310.7M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
WEYS
BCYC
Price
$34.54
$4.44
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
12.0K
356.1K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
3.24%
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
$276,169,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$54.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.25
$4.24
52 Week High
$35.69
$9.36

Technical Indicators

Market Signals
Indicator
WEYS
BCYC
Relative Strength Index (RSI) 55.13 38.55
Support Level $30.62 $4.24
Resistance Level N/A $5.31
Average True Range (ATR) 1.38 0.21
MACD 0.10 -0.04
Stochastic Oscillator 75.59 19.27

Price Performance

Historical Comparison
WEYS
BCYC

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: